Sarepta Therapeutics Stocks List Ranked for 2024 |

	Symbol	Grade	Name	% Change
	SRPT	B	Sarepta Therapeutics, Inc.	2.32

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
PINK	C	Simplify Health Care ETF	8.61
IDNA	C	iShares Genomics Immunology and Healthcare ETF	5.83
IBRN	D	iShares Neuroscience and Healthcare ETF	4.65
GNOM	D	Global X Genomics & Biotechnology ETF	4.4
BBP	D	BioShares Biotechnology Products Fund	2.84

Compare ETFs

Compare GNOM to BBP Compare IDNA to BBP Compare PINK to BBP

Date	Stock	Title
May 3	SRPT	Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
May 2	SRPT	Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says
May 2	SRPT	Sarepta Elevidys accelerated approval criticized by ICER exec
May 2	SRPT	Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
May 2	SRPT	Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
May 2	SRPT	Q1 2024 Sarepta Therapeutics Inc Earnings Call
May 2	SRPT	Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
May 1	SRPT	Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 1	SRPT	Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
May 1	SRPT	Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript
May 1	SRPT	Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
May 1	SRPT	Sarepta Therapeutics jumps 5% on Q1 beats
May 1	SRPT	Sarepta Therapeutics Non-GAAP EPS of $0.73 beats by $0.43, revenue of $413.5M beats by $43.02M
May 1	SRPT	Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
May 1	SRPT	1 Top Growth Stock to Buy and Hold for 10 Years
Apr 30	SRPT	Sarepta Therapeutics Q1 2024 Earnings Preview
Apr 30	SRPT	Why Sarepta (SRPT) Might Surprise This Earnings Season
Apr 29	SRPT	Sarepta Therapeutics Stock Shows Improved Technical Strength

Related Industries: Biotechnology

Sarepta Therapeutics: Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of the end of 2019, the company has two approved drugs (see the Products section below).